News Overview

Orchid Pharma Limited has informed the Exchange about Investor Presentation

Eicher Motors Limited has informed the Exchange about appointment of Vidhya Srinivasan as Chief Financial Officer of the company w.e.f. 18-Nov-2022

BASF India Limited has informed the Exchange about the Presentation made to the Analysts / Fund Managers on 18th November 2022 at 4 p.m.

JSW Energy Limited has informed the Exchange about Affirmation of Credit Rating of JSW Renewable Energy (Vijayanagar) Limited

Bharti Airtel Limited has informed the Exchange about press release dated 18-Nov-2022 titled Airtel powers Lal Bahadur Shastri International Airport, Varanasi with ultrafast Airtel 5G Plus.

Aurobindo Pharma Limited is pleased to announce that its wholly owned subsidiary company, Eugia Pharma Specialities Limited, has received a final approval from the US Food & Drug Administration (USFDA) for Amphotericin B Liposome for Injection, 50 mg. Amphotericin B Liposome for Injection, 50 mg/vial Single-Dose Vial to be bioequivalent and therapeutically equivalent to the reference listed drug (RLD), AmBisome Liposome for Injection, 50 mg/vial, of Astellas Pharma US, Inc.. The product is expected to be launched by Q4 FY23. The approved product has an estimated market size of around US$ 145 million for the twelve months ending September 2022, according to IQVIA.

COMPLIANCE OF REGULATION 30 OF SEBI (LODR), 2015- DISCLOSURE OF EVENTS OR INFORMATION ??? CESSATION OF DIRECTORS

LG Balakrishnan & Bros Limited has informed the Exchange about Notice of Postal Ballot

MRF Limited has informed the Exchange about Notice of Postal Ballot

Indian Energy Exchange Limited has informed the Exchange about Closure of trading window